Sarissa Capital Management LP

CIK 0001577524 · GREENWICH, CT · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Sarissa Capital Management LP reported 10 positions worth $177.9M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: INVA (24.1%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$177.9M
2026 Q2
Positions
10
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
100.0%
Est. Net Flow (Q)
2026 Q2
10 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1INVAINNOVIVA INCSH$42.9M24.14%1,890,604
2IRWDIRONWOOD PHARMACEUTICALS INCSH$38.7M21.75%9,188,635
3AMRNAMARIN CORP PLCSH$26.7M15.00%1,673,395
4NBIXNEUROCRINE BIOSCIENCES INCSH$19.6M11.04%116,533
5CYTKCYTOKINETICS INCSH$19.5M10.95%228,623
6LNTHLANTHEUS HLDGS INCSH$18.5M10.41%166,919
7BHVNBIOHAVEN LTDSH$8.7M4.87%582,312
8REGNREGENERON PHARMACEUTICALSSH$2.6M1.47%4,190
9VORVOR BIOPHARMA INCSH$467.6K0.26%25,399
10BIIBBIOGEN INCSH$205.3K0.12%950

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Sarissa Capital Management LP hold as of Q2 2026?

Sarissa Capital Management LP reported 10 positions worth $177.9M in its Q2 2026 13F filing. Largest positions: INVA (24.1%), IRWD (21.7%), AMRN (15.0%), NBIX (11.0%) and CYTK (10.9%).

What did Sarissa Capital Management LP buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Sarissa Capital Management LP sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.